Cypress Asset Management Inc. TX increased its position in shares of Clorox Co (NYSE:CLX) by 64.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,365 shares of the company’s stock after buying an additional 2,885 shares during the period. Cypress Asset Management Inc. TX’s holdings in Clorox were worth $1,182,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. Visionary Asset Management Inc. acquired a new position in Clorox in the fourth quarter valued at approximately $225,000. Deutsche Bank AG grew its holdings in Clorox by 10.2% in the 4th quarter. Deutsche Bank AG now owns 307,703 shares of the company’s stock valued at $47,425,000 after buying an additional 28,361 shares in the last quarter. Phocas Financial Corp. purchased a new stake in Clorox in the 4th quarter valued at $193,000. Oregon Public Employees Retirement Fund lifted its stake in shares of Clorox by 48,033.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,808,980 shares of the company’s stock valued at $44,000 after purchasing an additional 6,794,834 shares during the last quarter. Finally, Montecito Bank & Trust lifted its stake in shares of Clorox by 24.0% in the 1st quarter. Montecito Bank & Trust now owns 5,212 shares of the company’s stock valued at $836,000 after purchasing an additional 1,009 shares during the last quarter. Hedge funds and other institutional investors own 77.91% of the company’s stock.
Shares of CLX traded up $2.42 during midday trading on Wednesday, reaching $150.60. 1,050,059 shares of the company were exchanged, compared to its average volume of 1,046,028. The company has a debt-to-equity ratio of 2.93, a current ratio of 1.10 and a quick ratio of 0.66. Clorox Co has a 1-year low of $118.92 and a 1-year high of $167.70. The stock has a market cap of $18.73 billion, a PE ratio of 24.06, a P/E/G ratio of 4.28 and a beta of 0.31.
Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, May 1st. The company reported $1.44 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.47 by ($0.03). Clorox had a return on equity of 108.82% and a net margin of 12.68%. The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.57 billion. During the same quarter last year, the firm posted $1.37 EPS. The company’s revenue was up 2.2% compared to the same quarter last year. On average, research analysts anticipate that Clorox Co will post 6.29 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be paid a $1.06 dividend. This is a boost from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date of this dividend is Tuesday, July 30th. This represents a $4.24 annualized dividend and a dividend yield of 2.82%. Clorox’s payout ratio is 61.34%.
CLX has been the topic of a number of analyst reports. Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating in a research report on Wednesday, April 24th. BMO Capital Markets set a $168.00 price target on Clorox and gave the company a “buy” rating in a report on Thursday, May 2nd. Citigroup lowered their price objective on Clorox from $171.00 to $160.00 and set a “neutral” rating for the company in a research report on Thursday, May 2nd. Argus downgraded Clorox from a “buy” rating to a “hold” rating in a research report on Monday. Finally, Deutsche Bank raised Clorox from a “sell” rating to a “hold” rating and set a $139.00 price target for the company in a research report on Thursday, May 2nd. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $149.57.
In related news, SVP Andrew J. Mowery sold 5,340 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $156.44, for a total value of $835,389.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.40% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was first posted by Sundance Herald and is the property of of Sundance Herald. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://sundanceherald.com/2019/05/22/cypress-asset-management-inc-tx-acquires-2885-shares-of-clorox-co-clx.html.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: Purposes and Functions of the Federal Reserve
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.